• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

餐后血糖作为2型糖尿病患者心血管疾病的危险因素:流行病学证据

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

作者信息

Bonora E, Muggeo M

机构信息

Division of Endocrinology and Metabolic Disease, University of Verona Medical School, Ospedale Maggiore, Piazzale Stefani 1, Verona, Italy.

出版信息

Diabetologia. 2001 Dec;44(12):2107-14. doi: 10.1007/s001250100020.

DOI:10.1007/s001250100020
PMID:11793012
Abstract

That cardiovascular disease occurs more frequently in patients with Type II (non-insulin-dependent) diabetes mellitus has been recognized for a long time. However, the extent to which hyperglycaemia contributes to atherosclerosis and cardiovascular disease is still not clear. Epidemiological studies published in recent years suggest that postprandial blood glucose might be an independent risk factor of cardiovascular disease. The main results of these studies, which are reviewed in this article, are that subjects from the general population with mild to moderate hyperglycaemia, following oral glucose load, but not in the fasting state, showed an increased cardiovascular risk. Furthermore, the post-challenge as well as postprandial glucose concentrations of subjects with Type II diabetes were found to be directly associated to incident cardiovascular disease independently of fasting glucose. Also, the correction of fasting hyperglycaemia or HbA1 c or both, disregarding the specific correction of postprandial hyperglycaemia was not found to significantly reduce the incidence of cardiovascular disease in patients with Type II diabetes. Finally, the strict control of both preprandial and postprandial hyperglycaemia yielded a substantial reduction of cardiovascular disease in Type II diabetes. Trials specifically designed to address this issue are needed to determine whether postprandial hyperglycaemia plays an independent and causative role in cardiovascular disease in patients with Type II diabetes.

摘要

心血管疾病在II型(非胰岛素依赖型)糖尿病患者中更为常见,这一点早已为人所知。然而,高血糖在动脉粥样硬化和心血管疾病中所起作用的程度仍不明确。近年来发表的流行病学研究表明,餐后血糖可能是心血管疾病的独立危险因素。本文综述了这些研究的主要结果,即一般人群中轻度至中度高血糖的受试者,在口服葡萄糖负荷后而非空腹状态下,心血管风险增加。此外,发现II型糖尿病患者的餐后血糖浓度以及口服葡萄糖耐量试验后血糖浓度与心血管疾病的发生直接相关,且独立于空腹血糖。而且,在不考虑餐后高血糖的具体纠正措施的情况下,单纯纠正空腹高血糖或糖化血红蛋白(HbA1c)或两者,并未发现能显著降低II型糖尿病患者心血管疾病的发病率。最后,严格控制餐前和餐后高血糖可使II型糖尿病患者的心血管疾病大幅减少。需要专门设计针对这一问题的试验,以确定餐后高血糖在II型糖尿病患者的心血管疾病中是否起独立的致病作用。

相似文献

1
Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.餐后血糖作为2型糖尿病患者心血管疾病的危险因素:流行病学证据
Diabetologia. 2001 Dec;44(12):2107-14. doi: 10.1007/s001250100020.
2
[Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].[餐后高血糖。餐后血糖波动、心血管疾病及糖尿病晚期并发症]
Ugeskr Laeger. 2003 Aug 11;165(33):3149-53.
3
Mechanisms of tissue damage in the postprandial state.餐后状态下组织损伤的机制。
Int J Clin Pract Suppl. 2001 Sep(123):7-12.
4
Post-challenge hyperglycaemia is associated with premature death and macrovascular complications.激发后高血糖与过早死亡和大血管并发症相关。
Diabetologia. 2003 Mar;46 Suppl 1:M17-21. doi: 10.1007/s00125-002-0932-4. Epub 2002 Nov 7.
5
Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.血糖控制对于2型糖尿病全病程中有效降低心血管风险至关重要。
Ann Med. 2005;37(4):250-8. doi: 10.1080/07853890510037365.
6
Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.餐后高血糖与糖尿病的心血管并发症:最新进展
Nutr Metab Cardiovasc Dis. 2006 Oct;16(7):453-6. doi: 10.1016/j.numecd.2006.05.006. Epub 2006 Aug 24.
7
Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice.2型糖尿病中的餐后高血糖:病理生理学方面、目的论概念及临床实践要点
Diabetes Metab Res Rev. 2004 Nov-Dec;20 Suppl 2:S13-23. doi: 10.1002/dmrr.528.
8
Post-challenge hyperglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events.餐后高血糖而非空腹高血糖是心血管疾病事件的独立危险因素。
Clin Lab. 2004;50(9-10):609-15.
9
Role of postprandial hyperglycemia in cardiovascular disease.餐后高血糖在心血管疾病中的作用。
Expert Rev Cardiovasc Ther. 2008 Jul;6(6):859-72. doi: 10.1586/14779072.6.6.859.
10
Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.2型糖尿病中的餐后代谢紊乱与心血管疾病
Postgrad Med J. 2005 Jan;81(951):1-6. doi: 10.1136/pgmj.2004.020511.

引用本文的文献

1
Gene variations and sweet taste sensitivity in Zambian adults with and without type 2 diabetes mellitus.患有和未患2型糖尿病的赞比亚成年人的基因变异与甜味敏感度
PLoS One. 2025 Jul 18;20(7):e0328172. doi: 10.1371/journal.pone.0328172. eCollection 2025.
2
BuZhong YiQi Formula Alleviates Postprandial Hyperglycemia in T2DM Rats by Inhibiting α-Amylase and α-Glucosidase In Vitro and In Vivo.补中益气方通过体内外抑制α-淀粉酶和α-葡萄糖苷酶减轻2型糖尿病大鼠餐后高血糖。
Pharmaceuticals (Basel). 2025 Feb 2;18(2):201. doi: 10.3390/ph18020201.
3
Ultrasound-assisted extraction of polyphenols from leaves and their α-glucosidase inhibition.
超声辅助从叶片中提取多酚及其对α-葡萄糖苷酶的抑制作用。
Front Nutr. 2025 Jan 29;12:1542217. doi: 10.3389/fnut.2025.1542217. eCollection 2025.
4
Acute hyperglycemia induces podocyte apoptosis by monocyte TNF-α release, a process attenuated by vitamin D and GLP-1 receptor agonists.急性高血糖通过单核细胞释放肿瘤坏死因子-α(TNF-α)诱导足细胞凋亡,这一过程可被维生素D和胰高血糖素样肽-1(GLP-1)受体激动剂所减弱。
J Steroid Biochem Mol Biol. 2025 Mar;247:106676. doi: 10.1016/j.jsbmb.2025.106676. Epub 2025 Jan 14.
5
Exploring dihydropyrimidone derivatives as modulators of carbohydrate catabolic enzyme to mitigate diabetes.探索二氢嘧啶酮衍生物作为碳水化合物分解代谢酶调节剂以缓解糖尿病。
Sci Rep. 2024 Dec 30;14(1):31761. doi: 10.1038/s41598-024-82765-1.
6
Bioassay Guided Isolation and α-Glucosidase Inhibition Studies of a New Sesquiterpene from .一种新倍半萜的生物测定导向分离及α-葡萄糖苷酶抑制研究 (原文中“from”后面缺少具体来源信息)
Curr Top Med Chem. 2025;25(3):311-317. doi: 10.2174/0115680266318007240924174634.
7
Inhibitory Mechanism of Camellianin A against α-Glucosidase: In Vitro and Molecular Simulation Studies.茶黄素A对α-葡萄糖苷酶的抑制机制:体外及分子模拟研究
Foods. 2024 Sep 6;13(17):2835. doi: 10.3390/foods13172835.
8
Recent Advances of Nanogenerator Technology for Cardiovascular Sensing and Monitoring.用于心血管传感与监测的纳米发电机技术的最新进展
Nano Energy. 2023 Dec 1;117. doi: 10.1016/j.nanoen.2023.108910. Epub 2023 Sep 18.
9
Association of the Ratio of Glycoalbumin to Hemoglobin A1c With Season Change and the COVID-19 Pandemic in Patients With Type 2 Diabetes Mellitus.2型糖尿病患者糖化白蛋白与糖化血红蛋白A1c比值与季节变化及COVID-19大流行的关联
Cureus. 2024 Jul 13;16(7):e64444. doi: 10.7759/cureus.64444. eCollection 2024 Jul.
10
Effect of pharmacological selectivity of SGLT2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes: a meta-analysis.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂的药理选择性对2型糖尿病患者心血管结局的影响:一项荟萃分析。
Sci Rep. 2024 Jan 25;14(1):2188. doi: 10.1038/s41598-024-52331-w.